Browse Category

Stocks News 3 October 2025 - 4 October 2025

Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (NASDAQ: CDTX) 2025 Investment Analysis – Will This Anti‑Flu Innovator Keep Soaring?

2025 Year‑to‑Date Stock Performance Cidara’s stock has been among the best performers in biotech. According to YTDReturn.com, a US$10,000 investment on 31 Dec 2024 would have grown to ~US$37,943 by 3 Oct 2025 because the share price increased from US$26.88 to US$101.99, a 279.43 % YTD return Ytdreturn. Zacks similarly reported a 217.8 % YTD rally by late September Nasdaq, reflecting further gains in October. The…
Rigetti Computing’s Quantum Leap: Stock Soars on Breakthroughs and Bold Bets

Rigetti (RGTI) Quantum Stock Rockets on Big Deals – Is the $10B Hype Real?

Key Facts: Rigetti’s stock is near record highs (~$35–39 as of Oct 3, 2025 Nasdaq), giving it a market capitalization around $11.5 billion Public (up ~2,500% over 12 months Public). 2025 has seen an enormous rally (RGTI is up ~127% YTD Tipranks), fueled by major contracts. In late September 2025 Rigetti announced $5.7M in new Novera quantum computer orders Datacenterdynamics…
Mercurity Fintech (MFH) Stock Explodes Amid Crypto & AI Bets – 1,000% Rally or Bubble?

Mercurity Fintech (MFH) Stock Explodes Amid Crypto & AI Bets – 1,000% Rally or Bubble?

Key Facts: Mercurity Fintech Holding Inc (NASDAQ: MFH) is a small-cap “next-gen fintech” company (market cap ~$1.3 B) focused on blockchain/digital assets, AI infrastructure, and financial services Tipranks. In 2025 the stock has soared – roughly +1,320% year-to-date – hitting about $28 by Oct 3 Tradingview. Its 52-week range is ~$1.03–$24.99; October 2025 trading has seen wild swings (e.g. +15.8% Oct 2 and…
USA Rare Earth (USAR) Stock Skyrockets on Major UK Acquisition and White House Talks

USA Rare Earth Stock Rockets on White House Rare-Earth Buzz – What You Need to Know

Stock Performance on Yahoo Finance USA Rare Earth trades on Nasdaq under ticker USAR. In the week leading up to Oct. 3, 2025, USAR’s stock price surged dramatically. For example, on Oct. 2 after-hours trading, shares jumped ~10% to about $24.93 Seekingalpha, and by midday Oct. 3 they were around $26.00 (up ~15% on the day) Stockanalysis. This was an all-time high…
MicroStrategy (MSTR) on Oct. 2 2025: Why the Bitcoin Treasury King Keeps Making Headlines

MicroStrategy (MSTR) Stock Skyrockets on Crypto Tax Break – Is a 50% Rally Next?

Today’s Stock Performance (Oct 3, 2025) MicroStrategy stock has been volatile this week amid crypto news. On Oct 1 it leapt ~+6% intraday (to ~$343) when Strategy filed an SEC update explaining that Treasury/IRS rules exempt crypto gains from the new minimum corporate tax Stocktwits. That rally carried into the close. Yesterday (Oct 2) MSTR opened around $348.57, traded as high as…
QuantumScape (QS) Stock Skyrockets 14% on Solid-State EV Battery Breakthrough – Can the Rally Continue?

QuantumScape (QS) Stock Skyrockets 14% on Solid-State EV Battery Breakthrough – Can the Rally Continue?

Key Stock Facts (as of Oct 3, 2025): QuantumScape (NYSE: QS) is trading around $16.35 (up ~14.3% intraday) Stockanalysis, giving it a market capitalization near $9.25 billion Stockanalysis. That price is just below its 52-week high of $16.45 Stockanalysis, and represents a ~+172% gain year-to-date Tradingview. QS has about 566 million shares outstanding Stockanalysis and a beta of ~4.4, reflecting very high volatility Stockanalysis. Analysts are largely bearish: the…
Rolls-Royce Soars to Record High: What’s Fueling the Unstoppable Rally?

Rolls-Royce Rockets 40%+ in 2 Years: Jet Engine Boom and £11B Submarine Deal Fuel Rally

Current Stock Performance (Oct 2025) Rolls-Royce shares are at multi‑year highs after a remarkable rally. On Oct 3, 2025 the stock was around 1,176.5p Reuters, near its all-time peak (1,196p) Reuters. This compares with only ~520p a year ago – a +124% gain Nasdaq. The 2‑year surge is roughly +400%, reflecting a turnaround since mid‑2023 Reuters. The stock trades at a…
Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Stock Performance (Oct 3, 2025) As of midday Oct 3, Humana shares were $272.05, up about +6.01% on the day Reuters. Yesterday’s close (Oct 2) was $256.62 Reuters, so HUM has recovered much of last week’s slide. In fact, Oct 1 saw a ~5% drop (on news of scaling back Medicare Advantage plans) Finviz, but Oct 2’s star rating news spurred a ~3% gain Reuters.…
Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (CDTX) Stock Soars After $339M BARDA Flu-Drug Deal – Is CD388 the Next Big Flu-Fighter?

Cidara Trading on Oct 3, 2025 On Friday morning Oct 3, CDTX was trading around $104 per share, up roughly 5.7% from Thursday’s close Finviz. Trading volumes are high as investors digest the Oct 2 BARDA award news. (Finviz shows a sharp jump on Oct 2: GlobeNewswire’s BARDA release coincides with a ~5.7% stock bump Finviz.) Cidara’s one-year chart is steeply upward – from around…
3 October 2025
🚀 CleanSpark (CLSK) Stock Surges on $120K Bitcoin Rally and $200M Crypto Credit Boost

🚀 CleanSpark (CLSK) Stock Surges on $120K Bitcoin Rally and $200M Crypto Credit Boost

Stock Price & Technical Snapshot (Oct 3, 2025) After early trading on Oct 3, CLSK sits around $16.10 (up +6.3% from prior close) Reuters, within its intraday range of $15.43–$16.12 Reuters. Volume is ~13.7 million shares (vastly above its ~0.52 M 3-month average) Reuters, indicating heavy buying interest. The 52‑week range is $6.45–$17.97, so CLSK is nearing its high. Key technicals from TipRanks show a 69…
Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast’s stock has surged recently on the Ryoncil news. At the Oct 2 close it stood at $17.02 – up +4.6% on the day and roughly +8% from two weeks prior Stockinvest Marketbeat. This rally follows last week’s announcements: on Sept 26 the company announced its therapies are U.S.-origin and exempt from tariffs Nasdaq, and on Oct 2 it disclosed…
1 83 84 85 86 87 89

Stock Market Today

  • SBM Offshore Reports EUR141 Million Share Repurchase Program Update
    January 21, 2026, 1:35 PM EST. SBM Offshore disclosed details of its ongoing EUR141 million (approx. US$150 million) share repurchase program spanning from April 24, 2025, to January 21, 2026. The company has completed 88.56% of the program, with cumulative repurchases totaling over 5.6 million shares at an average price of EUR22.14. In the last five trading days, nearly 91,000 shares were repurchased at an average price of EUR28.71, amounting to about EUR2.6 million. These shares were bought via Euronext Amsterdam, CBOE DXE, and Turquoise exchanges. The program aims to reduce share capital and support management and employee share schemes, reinforcing SBM Offshore's strategy to enhance shareholder value.
Go toTop